Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer

Advanced Nonsmall Cell Lung Cancer Clinical Trial

Official title:
Tumor-Associated Macrophages Correlate With Response and Outcomes in Advanced Non-Small Cell Lung Cancer After First Line Treatment.

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the effects of tumor associated macrophage (TAM) in advanced non-small cell lung cancer (NSCLC) patients on the treatment response and outcome of these subjects. Pathologic specimens from tissue bank will be stained by immunostaining methods with CD68 antibody. The clinical treatment response and outcomes will be analyzed between high or low TAM.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Advanced Nonsmall Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms

Clinical Trial Details

NCT number	NCT01551251
Study type	Observational
Source	Chang Gung Memorial Hospital
Contact
Status	Completed
Phase	N/A
Start date	January 2006
Completion date	December 2010

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02952729` - Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2	Phase 1
	Completed	`NCT00602433` - Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib	N/A